Tuttle KR, Levin A, Nangaku M, Kadowaki T, et al. Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials. Diabetes Care 2022 Apr 26. pii: 145036. doi: 10.2337/dc21-2034.
PMID: 35472672